Thursday, March 10, 2022

Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC

xlomafota13 shared this article with you from Inoreader

ooi210081f1_1646672275.44219.png?Expires

This study assesses whether there are changes on fluoro-[ 18F]-deoxy-2-D-glucose positron emission tomography/computed tomography scans in patients with oral cavity squamous cell cancer receiving neoadjuvant immunotherapy.
View on the web
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...